Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Goodwin Biotech Expands Bioconjugation Capabilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Goodwin Biotech Expands Bioconjugation Capabilities

Adds ADC manufacturing suite up to Safebridge level 4/5

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Goodwin Biotechnology, Inc. has recently expanded its Bioconjugation capabilities by adding a dedicated suite for developing and manufacturing cytotoxic Antibody Drug Conjugates (ADCs) up to Safebridge level 4/5.

“For over 15 years, Goodwin Biotechnology has been one of the pioneers in providing development and GMP manufacturing of a broad portfolio of  ADC projects, including cytotoxic ADCs, Radio-Immunoconjugates, Antibody-Peptide Conjugates, Antibody-Dye Conjugates, PEGylated proteins, other bioconjugates, and even Biobetters,” said Muctarr Sesay, Ph.D., chief scientific officer and vice president of Bioconjugation Development at Goodwin Biotechnology. “Our experience in Bioconjugation has resulted in several patents and publications, as well as proprietary processes that enable us to help our clients overcome some significant challenges in developing their next generation of ADCs.  Given the increasing interest in conjugating highly cytotoxic products (e.g., anti-cancer drugs) to enhance the efficacy of ADCs, we have added a dedicated ISO-7 Cytotoxic Process facility for Proof of Concept, development, Tox and cGMP manufacturing to address unmet clinical needs.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics